http://www.fda.gov/cder/orange/appendix_a.txt IRRIGANT, NEOMYCIN SULFATE NEOSPORIN, BACITRACIN ZINC NEOSPORIN, GRAMICIDIN NEOSPORIN, NEOMYCIN SULFATE (OTC) NEOTHYLLINE, DYPHYLLINE NEOTRIZINE, TRISULFAPYRIMIDINES (SULFADIAZINE;SULFAMERAZINE; SULFAMETHAZINE) NEPHRAMINE 5.4%, AMINO ACIDS NEPHROFLOW, IODOHIPPURATE SODIUM, I-123 NEPTAZANE, METHAZOLAMIDE NESACAINE, CHLOROPROCAINE HYDROCHLORIDE NESACAINE-MPF, CHLOROPROCAINE ...
21127_Optivar (Azelastine Hydrochloride) Food and Drug Administration • Center for Drug Evaluation and Research Approval Package Search Optivar (Azelastine Hydrochloride) Ophthalmic Solution Company:--ASTA Medica, Inc
author: Paul Stauffer
Prescription and Over-the-Counter Drug Product List: 4/2003 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; BUTALBITAL; CAFFEINE TABLET; ORAL FIORICET -D- AB + NOVARTIS 325MG;50MG;40MG N88616 001 NOV 09, 1984 APR CAHN -A- AB + WATSON PHARMS 325MG;50MG;40MG N88616 001 NOV 09, 1984 APR CAHN ACYCLOVIR CAPSULE; ORAL ACYCLOVIR -A- AB AAIPHARMA 200MG N74833 001 APR 22, 1997 APR CAHN -D- AB AESGEN 200MG N74833 001 APR 22, 1997...
author: AUTHOR
Prescription and OTC Drug Product List 5/2002 2 -D- + ROBINS AH 325MG;15MG N84444 001 MAY DISC -A- @ 325MG;15MG N84444 001 MAY DISC SOLUTION; ORAL ACETAMINOPHEN AND CODEINE PHOSPHATE -D- AA ALPHARMA 120MG/5ML;12MG/5ML N85861 001 MAY CRLD -A- AA + 120MG/5ML;12MG/5ML N85861 001 MAY CRLD TYLENOL W/ CODEINE -D- AA + JOHNSON RW 120MG/5ML;12MG/5ML N85057 001 MAY DISC -A- @ 120MG/5ML;12MG/5ML N85057 001 MAY DISC TABLET; ORAL...
OPTIVAR™ CDER USER OPTIVAR ™ Wiley AOPTIVAR ™ azelastine hydrochloride ophthalmic solution, 0.05% Description OPTIVAR ™ (azelastine hydrochloride ophthalmic solution) 0.05% is a sterile ophthalmic solution containing azelastine hydrochloride, a relatively selective H1-receptor antagonist for topical administration to the eyes
author: Wiley A. Chambers
http://www.fda.gov/cder/foi/label/2000/21127lbl.pdf BASIS FOR APPROVAL May 16, 2000 Page 1 Azelastine Hydrochloride Ophthalmic Solution, 0.05% NDA # 21- 127 OPTIVAR ™ azelastine hydrochloride ophthalmic solution, 0.05% DESCRIPTION OPTIVAR ™ (azelastine hydrochloride ophthalmic solution) 0.05% is a sterile ophthalmic solution containing azelastine hydrochloride, a relatively selective H1- receptor...
http://www.fda.gov/cder/foi/label/2000/21127lbl.pdf page 4
http://www.fda.gov/cder/foi/label/2000/21127lbl.pdf page 3
http://www.fda.gov/cder/foi/label/2000/21127lbl.pdf page 2
http://www.fda.gov/cder/foi/label/2000/21127lbl.pdf page 1
Seasonal Allergies: Allergic Reactions: Merck Manual Home Edition Search Recent Searches Index Sections A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Accidents and Injuries Blood Disorders Bone, Joint, and Muscle Disorders Brain, Spinal Cord, and Nerve Disorders Cancer Children's Health Issues Digestive Disorders Disorders of Nutrition and Metabolism Drugs Ear, Nose, and Throat Disorders Eye Disorders Fundamentals Heart and Blood Vessel...
Pediatric Exclusivity Labeling Changes Food and Drug Administration • Center for Drug Evaluation and Research Pediatrics Search Pediatric Exclusivity Labeling Changes as of February 6, 2004 - - Exclusivity Granted (Labeled) Product Indications Label Changes 1Azelastine - Optivar (Asta) Label [Word 97] Itching associated with Allergic Conjunctivitis Safety and effectiveness...
PPT Slide Labeling Changes - - Abacavir - Ziagen (HIV) Labeling for 3 months - 12 years - Ranitidine - Zantac (GERD) ExtAzelastine - Optivar (Itching assoc
http://www.fda.gov/cder/pediatric/reportcong01.pdf page 42
Drug Approvals - O NDA 20-899/SCM-007 5/10/02 5/29/02 OPTIVAR (azelastine hydrochloride ophthalmic solution), 0.05%, Rx ASTA Medica, IncOptivar Indications:- Treatment of itching of the eye, associated with allergic conjunctivitisHydrochloride Tablets,-15 & 30mg, Rx Amide...
Microsoft Word - RPSepicPOM A Aciclovir 6 Acrivastine 6 Aluminium chloride 6 Aspirin 8, 46 Astemizole 5 Atropine Sulphate 9 Azelastine 8, B Beclomethasone Dipropionate 6, 47 Benzocaine 47 Benzoyl Peroxide 46 Budesonide 8 C Cadexomer- Iodine 8 Camphor 47 Carbenoxolone 6 Cetirizine 6,47 Cimetidine 6 Chloramphenicol 9 Clobetasone 9 Clotrimazole 6,8,46 Co- methiamol 29 D Dequalinium chloride 46 Dextranomer 5...
Microsoft Word - RPSepicPOM page 3
http://www.fda.gov/cder/dmf/text/4Q2003ACTIVETYPE2TEXT.txt IN VIBY Sj., DENMARK" 8368 19-Dec-89 VIATRIS GMBH & CO KG AZELASTINE HCl AS MFGHYDROCHLORIDE, ...
20114S006_Astelin.htm Food and Drug Administration • Center for Drug Evaluation and Research Approval Package Search Astelin (Azelastine Hydrochloride) Nasal Spray Company:--Wallace Laboratories, Division of Carter-Wallace, Inc
author: Paul Stauffer
Prescription and OTC Drug Product List 10/2001 PEDIATRIC -D- + ASTRAZENECA 80MG/VIAL;0.02MG/VIAL;0.00 1MG/VIAL;5MG/VIAL;0.01MG/V IAL;0.14MG/VIAL;17MG/VIAL; 0.2MG/VIAL;1MG/VIAL;1.4MG/ VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/V IAL N18920 001 SEP 21, 2000 OCT CAHN -A- + NEOSAN PHARMS 80MG/VIAL;0.02MG/VIAL;0.00 1MG/VIAL;5MG/VIAL;0.01MG/V IAL;0.14MG/VIAL;17MG/VIAL; 0.2MG/VIAL;1MG/VIAL;1.4MG/ VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/V IAL...
http://www.rpsgb.org.uk/pdfs/mlx281.pdf PROFESSIONAL STANDARDS DIRECTORATE Chairman of the Law and Ethics Committee Telephone: 020 7572 2312 Facsimile: 020 7572 2510 e- mail: slutener@ rpsgb
http://www.rpsgb.org.uk/pdfs/mlx281.pdf page 1
FDA Drug Approvals List May 2000 - Drug Approvals for May 2000 Definitions and Notes Original New Drug Applications Original Application #: 021134 Approval Date: 01-MAY-00 Trade Name: NITROSTAT Chemical Type: 3 Therapeutic Potential: S Dosage Form: TABLET Applicant: PARKE DAVIS PHARMACEUTICALS LTD Active Ingredient(s): NITROGLYCERIN OTC/RX Status: RX Indication(s): For the acute relief of an attack or acute...
EFFICACY SUPPLEMENTS APPROVED IN CY 2000 Also, under GRANULES FOR ORAL SUSPENSION in the DOSAGE AND ADMINISTRATION section, the age range for children in the dosing tables was expanded to -age 5 months through 12 years.- SOTALOL HYDROCHLORIDE BERLEX LABS 21-151 22-Jun-98 22-Feb-00 N 000 N 20.1 Provides for the new indication of prolongation of time to recurrence of symptomatic AFIB/AFL in patients with symptomatic...
FDA Drug Approvals List- February 1999 Applicant: CONNETICS CORP Active Ingredient(s): BETAMETHASONE VALERATE OTC/RX Status: RX Indication(s):For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses of the scalp Original Application #: 020969 Approval Date: 25-FEB-99 Trade Name: UVADEX Chemical Type: 3 Therapeutic Potential: S Dosage Form: SOLUTION Applicant: THERAKOS INC...
